As researchers continue studying GLP-1 drugs like Ozempic and Mounjaro in a range of conditions beyond their approved uses, a growing body of evidence is pointing toward a meaningful role in cancer prevention and outcomes — with some of the…
GLP-1s
As retailers, payers and drugmakers expand access to GLP-1 therapies — with companies like Amazon and Walmart launching weight management programs — the drug class is reshaping both care delivery and pharmaceutical investment strategies. That demand is influencing drug development,…